COMP <GO>
OTEX vs DOX // FORWARD P/E MULTIPLE
Open Text Corporation (NASDAQ) VS. Amdocs Limited (NASDAQ) • 15-METRIC TALLY: OTEX 3
— DOX 11
▲ FORWARD P/E MULTIPLE LEADER: DOX
LAST: $26.52 (-0.26%) • MKT CAP: $6.66B
forward-pe
14.5x
LAST: $63.54 (+1.13%) • MKT CAP: $6.78B
forward-pe
12.6x
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (OTEX VS. DOX)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | OTEX | DOX | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 72.30% | 35.10% | +37.20 | OTEX | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 7.70% | 23.60% | -15.90 | DOX | /roic <GO> |
| EV/EBITDA & P/E Valuation | 10.9x | 9.7x | +1.20 | DOX | /valuation <GO> |
| Free Cash Flow Yield | 8.82% | 9.21% | -0.39 | DOX | /fcf-yield <GO> |
| Operating Margin | 17.30% | 12.60% | +4.70 | OTEX | /operating-margins <GO> |
| Net Profit Margin | 8.40% | 9.90% | -1.50 | DOX | /net-margins <GO> |
| Revenue Growth (YoY) | -10.40% | 2.40% | -12.80 | DOX | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 4.00% | 3.16% | +0.84 | OTEX | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 1.41 | 4.98 | -3.57 | DOX | /balance-sheet <GO> |
| Piotroski F-Score Quality | 5/9 | 7/9 | -2.00 | DOX | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 58.8 | 61.2 | -2.40 | DOX | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 1.36 | 1.39 | -0.03 | DOX | /macro-sensitivity <GO> |
| Forward P/E Multiple ACTIVE | 14.5x | 12.6x | +1.90 | DOX | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $6.66B | $6.78B | -$118.9M | DOX | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | OTEX REV | DOX REV | OTEX GROSS % | DOX GROSS % | OTEX FCF | DOX FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $5.17B | — | 72.3% | — | $598.0M | — |
| FY 2024 | $5.77B | $5.00B | 72.6% | 35.1% | $708.1M | $618.9M |
| FY 2023 | $4.48B | $4.89B | — | — | $577.4M | $602.7M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
OTEX // BETA 1.36
DOX // BETA 1.39